<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02164591</url>
  </required_header>
  <id_info>
    <org_study_id>Temp GES</org_study_id>
    <nct_id>NCT02164591</nct_id>
  </id_info>
  <brief_title>Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis</brief_title>
  <acronym>TempGES</acronym>
  <official_title>Escalating Temporary Gastric Electrical Stimulation for Severe Gastroparesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the physiologic effects of temporary gastric&#xD;
      electrical stimulation in subjects with severe gastroparesis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will look to determine the clinical benefit placing temporary gastric electrical&#xD;
      stimulation, the ability to predict the clinical response to surgical implantation of GES,&#xD;
      and the feasibility and patient tolerability of endoscopic placement of temporary Gastric&#xD;
      Electrical Stimulator (t-GES),&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">January 2019</completion_date>
  <primary_completion_date type="Actual">January 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in the symptoms of gastroparesis by t-GES in patients with severe gastroparesis.</measure>
    <time_frame>1 month</time_frame>
    <description>Review the symptoms before and after the t-GES placements and follow for any improvement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical response to t-GES placement as measured by questionnaires</measure>
    <time_frame>1 year</time_frame>
    <description>Measuring the responses to questionnaires before and after placement of GES</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Develop a prospective registry in patients undergoing escalating t-GES</measure>
    <time_frame>1 year</time_frame>
    <description>Have a database of patients undergoing t-GES placement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>determine the feasibility and patient tolerability of endoscopic placement of t-GES</measure>
    <time_frame>1 year</time_frame>
    <description>Determine if placement of t-GES is feasible and if the patients tolerate the t-GES</description>
  </secondary_outcome>
  <enrollment type="Actual">19</enrollment>
  <condition>Gastroparesis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum to be frozen&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who have been diagnosed with gatroparesis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 3 months of gastroparesis-related symptoms, such as nausea, emesis, and/or&#xD;
             retching&#xD;
&#xD;
          -  Solid phase 4-hr gastric scintigraphy is consistent with gastroparesis within 3 months&#xD;
             of study enrollment*&#xD;
&#xD;
               -  retention at 2 hr: &gt;60% or&#xD;
&#xD;
               -  retention at 4 hr: &gt;10% *Based on International consensus on gastric scintigraphy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Gastric outlet, small bowel, or colon obstruction.&#xD;
&#xD;
          -  Small bowel malrotation&#xD;
&#xD;
          -  Inflammatory bowel disease&#xD;
&#xD;
          -  Contraindication for surgical implantation of GES&#xD;
&#xD;
          -  Presence of illness that may require MRI during the study; such as pituitary tumor,&#xD;
             herniated disc, spinal stenosis, multiple sclerosis, etc.&#xD;
&#xD;
          -  Significant comorbidity due to sever cardiovascular, renal, pulmonary, or liver&#xD;
             disease.&#xD;
&#xD;
          -  Significant coagulopathy&#xD;
&#xD;
          -  Non-ambulatory patients: bed-ridden, nursing home resident, etc.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Unable to give own informed consent&#xD;
&#xD;
          -  Prisoners&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John M Wo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indiana University Hosptial</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>June 6, 2014</study_first_submitted>
  <study_first_submitted_qc>June 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2014</study_first_posted>
  <last_update_submitted>August 1, 2020</last_update_submitted>
  <last_update_submitted_qc>August 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>John M. Wo</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>gastroparesis</keyword>
  <keyword>gastric electrical stimulator</keyword>
  <keyword>GES</keyword>
  <keyword>vomiting</keyword>
  <keyword>nausea</keyword>
  <keyword>bloating</keyword>
  <keyword>postprandial fullness</keyword>
  <keyword>epigastric pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

